Radiology AI devices are more likely to face FDA recalls, largely due to deviations from intended use and incomplete clinical data.
Key Details
- 1New analysis looked at 903 healthcare AI devices approved by FDA between 1995 and 2024.
- 2Of these, 5% (43 devices) were recalled, with a median recall interval of 458 days.
- 3Radiology comprised 692 of these devices, with a 4.3% (30 devices) recall rate.
- 4Radiology AI devices are 52% more likely to face recall than AI devices in other specialties.
- 5Missing clinical study information and deviations from intended use were major risk factors for recall.
- 6Problems with temperature and labeling led to lower recall risk, while market surveillance flags increased it.
Why It Matters
This study is the first to systematically quantify recall risk factors for AI-enabled devices, highlighting the urgent need for rigorous validation and postmarket surveillance, especially within radiology. Increased transparency and robust premarket evaluation may help mitigate safety risks as AI adoption accelerates.
Source
Radiology Business
Related News
•AuntMinnie
MyChart Imaging Access Links Reduce Radiologist Workload and Improve Patient Care
Embedding imaging access links in MyChart portals significantly reduces manual workload for radiologists and increases patient engagement.
•AuntMinnie
Survey at SIIM Highlights Benefits and Adoption of Interactive Multimedia Reporting in Radiology
A University of Virginia survey presented at SIIM revealed radiologists have strong positive attitudes toward interactive multimedia reporting, citing efficiency and clarity gains.
•AuntMinnie
ONC Official at SIIM Calls for Smarter AI and Better Image Sharing
ONC's Dr. Jason Funderburk urges improvements in medical image sharing and AI readiness at SIIM 2024.